机译:新的欧洲批准:Duvelisib -复发/难治性慢性淋巴细胞白血病和滤泡淋巴瘤
CHU Montpellier,Univ Montpellier;
Follicular Lymphoma; Chronic lymphocytic leukemia; approval;
机译:再発小细胞肺癌(sensitive relapse and refractory relapse)
机译:消化管follicular lymphoma
机译:消化管follicular lymphoma
机译:DUO 3期临床试验:duvelisib vs ofatumatumb治疗复发和难治性CLL / SLL
机译:Duvelisib在Duo交叉扩展研究中复发/难治性CLL或SLL患者患者疾病进展后Duvelisib疾病的疗效和安全性